FAST NEURO BOOST - iPH short peptide complex for nervous system

FAST NEURO BOOST – its components support memory and concentration in adults, improve cognitive function under stress, reduce the negative impact of stress on the brain, supporting normal cognitive processes, regulate neurotransmitter function, support neuroplasticity, and help prevent neurodegenerative diseases of the central nervous system.

Active components:

COENZYME B12 (5'-DEOXYADENOSYLCOBALAMIN)

Coenzyme B12 (5'-deoxyadenosylcobalamin) is not just vitamin B12, but its active coenzyme form, which is immediately activated by the body. It is directly involved in mitochondrial processes, particularly in the conversion of fatty acids and amino acids into energy, supporting ATP production. This makes Coenzyme B12 critically important for:

• cellular metabolism,
• muscle and brain function,
• protection against metabolic disorders.

Unlike regular forms of B12, Coenzyme B12 does not require activation. It immediately activates energy metabolism. This is especially important for enzyme deficiencies, the elderly, chronic fatigue, and mitochondrial dysfunction. Coenzyme B12 (5'-deoxyadenosylcobalamin) plays a key role in nerve cell energy metabolism and the protection of their sheath, myelin. Scientific research shows that adequate levels of vitamin B12 prevent damage to the myelin sheath and improve nerve fiber recovery after injury.
Clinical trials have confirmed that B12 replenishment helps slow the progression of cognitive impairment and neurodegenerative processes, especially in the elderly.

IPH GAA PEPTIDE COMPLEX (BRAIN PEPTIDE)

The IPH GAA peptide, composed of glutamic acid, aspartic acid, and arginine, is a powerful regulator of neural activity derived from Echinoidea sea urchins. Due to its small size, it easily crosses the blood-brain barrier and acts directly on brain cells. Research has shown that this peptide improves memory and concentration, promotes the formation of new nerve cells (neurogenesis), and increases the brain's resilience to stress.
The IPH GAA peptide has also proven effective in the prevention of dementia and other cognitive impairments, as confirmed by numerous experimental and clinical observations.
The study "IPH GAA PEPTIDE COMPLEXES AS REGULATORS OF COGNITIVE FUNCTIONING AND DEFICIENCY AND THEIR ROLE IN ENHANCEMENT OF THE BIOLOGICAL RESOURCES OF LIVING SYSTEMS (2022, Russian Federation)"
confirms the cytoprotective properties of the IPH GAA peptide and its ability to regulate normal brain development and cognitive abilities at the gene level, as well as its strong oncoprotective and antioxidant functions in the brain. Administration of the IPH GAA peptide significantly reduces neuroinflammation in patients with moderate neurodegenerative disorders by 82.3% over the long term, and helps slow the progression of neurodegenerative disorders by 2.1 times, confirming the IPH GAA peptide's strong antioxidant and immune functions in the brain over the long term. Clinically, the use of the IPH GAA peptide can have a beneficial effect on cognitive functioning, which was reflected in a 37.8% reduction in the severity of dizziness, 38.9% reduction in difficulty concentrating, 24.5% increase in attention, 27.8% improvement in reaction time, 68.7% reduction in the severity of cognitive deficits, and 44.3% improvement in sleep parameters over the long term (1 year).

SIALIC ACID (N-ACETYL-D-NEURAMINIC ACID)

Sialic acid is a vital component of brain cell membranes, especially necessary during periods of active brain growth and development, as well as for maintaining cognitive function in adulthood. Adequate sialic acid intake has been clinically proven to improve memory and learning. Regular supplementation is especially important, as it influences intellectual development and the formation of neural connections. In studies using Alzheimer's disease models, sialic acid supplementation helped slow the progression of the disease and significantly improved cognitive function.
N-acetylneuraminic acid acts as an important neurometabolite and signaling molecule in the brain. It is essential for ganglioside synthesis and the normal formation of synaptic connections, supporting neuroplasticity in both children and adults. Sialic acid supplementation (e.g., as part of glycoconjugates or in free form) is considered a promising approach to support cognitive function and prevent neurodegeneration due to its neurotrophic, neuroprotective, and anti-inflammatory effects.

* NRVs - nutrient reference values

Effect:

• Improves memory and concentration, supporting normal cognitive function
• Enhances the brain's ability to adapt and recover from stress, reduces the negative impact of stress on the brain
• Protects nerve cells from damage and inflammation, supports neuroplasticity
• Helps prevent age-related cognitive decline and neurodegenerative diseases
• Source of coenzyme B12, sialic acid, and IPH GAA peptide

Recommendation for use:

• For the prevention of neurodegenerative and inflammatory diseases of the central nervous system
• As part of the complex treatment of CNS pathologies of various origins
• For cognitive disorders (memory impairment, decreased ability to concentrate);
• When cognitive function needs to be expanded
• Under high intellectual stress
• As a source of coenzyme B12, sialic acid, and the IPH GAA peptide

FAST NEURO BOOST is a unique product for supporting cognitive health and preventing age-related brain diseases.

TRANSBUCCAL-SUBLINGUAL DISSOLVING SYSTEM (TRIPS)

This is a thin film or ultra-thin tablet that quickly disintegrates in the mouth.
When placed on the oral mucosa, this formulation rapidly releases the active ingredient, which is absorbed directly into the systemic bloodstream through the oral mucosa, bypassing the gastrointestinal tract.

Advantages of TRIPS:

• Speed, effectiveness, compliance.
• Predictability of effect.
• Convenience and patient compliance.
• Safety and the ability to interrupt administration.

Method of applicattion:

Adults take 3 trips 3 times daily. Duration of treatment: 1 month: 21 days of treatment, then a 9-day break. Treatment can be repeated if necessary.

Release form:

189 lozenges (dispersible films) - 21 cases of 9 lozenges (trips).

Contraindications:

Individual intolerance to the components of the dietary supplement, pregnancy, or breastfeeding. Consult a physician before use.

Guaranteed authenticity and quality:

100% Original from MD-consultant (Russia)

Development and production:

IDEAL PHARMA PEPTIDE GmbH (Germany) - Peptide complexes by Ideal Pharma Peptide for food and beauty industries, for sport and food supplements. Sophisticated, high-tech process of the peptide and peptide complex production implies the presence of complex biotechnological innovations and techniques, enormous scientific and laboratory facilities, it allows the company to take the leading place in a new segment of the market of peptides and commodity systems based on them.

Peptide complexes for the pharmaceutical, food and cosmetic industry for the production of sports nutrition and dietary supplements designed by Ideal Pharma Peptide GmbH were the epitome of the results of global research. Peptide complexes we offer represent high-tech raw materials ready for use in your ambitious plans. This is an opportunity to create innovative products and bring them to market.

MANUFACTURING

Foundation of the company - 1997

The company's production facilities and official branches are located in Germany, Japan, Russia and other countries.

IDEAL PHARMA PEPTIDE specializes in the development of manufacturing technologies and quality control methods for short peptides consisting of amino acid residues derived from

sea clams, Pacific oyster, scallop, sea urchins and deep sea fish.

QUALITY OF THE RAW MATERIAL

IPH peptide complexes have a guaranteed content of short peptides, confirmed by high-precision HPLC (High performance liquid chromatography) technique.

IDEAl PHARMA PEPTIDE has a permanent and deep cooperation with the German Frauhhofer Institute of Biotechnology and Fresenius, the largest European quality certification center.

All used methods for controlling IPH peptides are prescribed in world pharmacopeias such as USP (American Pharma), BP (British Pharma), EP (European Pharma) and JP (Japanese Pharma).

They have patent protection: patent in the United States of America No. 5,405,266, patent in the European Union No. 016704471, patent in the Russian Federation No. 645608, patent in the People's Republic of China No. 30507522).

Modern technologies for the production of IPH peptides completely repeat the natural processes of our body.

IPH peptides are at the service of more than fifty companies in the world - from medicine and pharmacology, to cosmetics and dietary supplements, sports and diabetic nutrition.

PATENTS AND SERTIFICATES

United States Patent No. 5,405,266
patent in the European Union No. 016704471
patent in the Russian Federation No. 645608
patent in the People's Republic of China No. 30507522
IPH peptides have all approvals and permissions for world markets, such as:

WADA certificate (anti-doping)
MAFFA certificate (safety),
ORGANIC certificate (organic origin),
HALAL certificate

PRO PEPTIDES are produced on the basis of IPH peptides by order of MD-consultant (Russia)